Abstract : Background: : There are considerable geographical differencesin the occurrence of extended-spectrum beta-lactamase(ESBL)-producing bacteria, both in the community and in thehospital setting. Our aim was to assess risk factors forbloodstream, urinary tract, and vascular catheter-associatedinfections with ESBL-producing Escherichia coli and Klebsiellapneumoniae at a tertiary care hospital in a low-prevalencecountry. Methods: : We performed a case-control study comparing 58patients with infections due to ESBL-producing E. coli orK. pneumoniae vs 116 controls with infections due to non-ESBL producing organisms at the University Hospital Zurich,Switzerland, between 1 July 2005 and 30 June 2007. Results: : Cases included 15 outpatients...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...
Introduction: Extended-spectrum beta-lactamase (ESBL) producing bacteria have been increasingly repo...
AbstractThe objective of this study was to identify risk factors for bacteremia by extended-spectrum...
ABSTRACTRisk-factors for bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-produ...
Introduction: Production of extended spectrum beta lactamase (ESBL) is an important mechanism of an...
Background/PurposeThe risk factors for production of extended-spectrum β-lactamases (ESBLs) have rar...
Background: Extended-spectrum β-lactamases (ESBLs) are an increasing challenge in the treatment of u...
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli cause up to 10% of catheter-assoc...
AbstractThe objective of this study was to identify risk factors for bacteremia by extended-spectrum...
To investigate the risk factors, prognosis and resistance to antibiotics in patients with extended-s...
AbstractPatients newly admitted to rehabilitation centres are at high risk of colonization with mult...
Background: Antimicrobial resistance due to production of extended-spectrum ß-lactamases by Escheric...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...
Introduction: Extended-spectrum beta-lactamase (ESBL) producing bacteria have been increasingly repo...
AbstractThe objective of this study was to identify risk factors for bacteremia by extended-spectrum...
ABSTRACTRisk-factors for bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-produ...
Introduction: Production of extended spectrum beta lactamase (ESBL) is an important mechanism of an...
Background/PurposeThe risk factors for production of extended-spectrum β-lactamases (ESBLs) have rar...
Background: Extended-spectrum β-lactamases (ESBLs) are an increasing challenge in the treatment of u...
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli cause up to 10% of catheter-assoc...
AbstractThe objective of this study was to identify risk factors for bacteremia by extended-spectrum...
To investigate the risk factors, prognosis and resistance to antibiotics in patients with extended-s...
AbstractPatients newly admitted to rehabilitation centres are at high risk of colonization with mult...
Background: Antimicrobial resistance due to production of extended-spectrum ß-lactamases by Escheric...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
AIMS: To estimate the prevalence of extended-spectrum-β-lactamase (ESBL)-producing enterobacterales ...
PURPOSE: Inadequate empirical therapy for severe infections caused by extended-spectrum β-lactamase-...